Type I sFGR is characterized by good perinatal outcome with expectant management, which represents the most reasonable management strategy for the large majority of affected cases. Pregnancies complicated by Type II and III sFGR treated with fetoscopic laser ablation had higher mortality but lower morbidity compared to those managed expectantly, supporting the use of fetal therapy at gestations remote from neonatal viability - with scarce data on outcome following selective reduction. However, in view of the lack of evidence from randomized controlled trials, prenatal management of sFGR should be individualized according to gestational age at diagnosis, severity of growth discordance and magnitude of Doppler anomalies. This article is protected by copyright. All rights reserved.